ARCHIVES

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

This article is from The Cancer Letter archive.

Vol. 04 No. 33 | August 18, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

“Don’t Judge Me On a Snapshot In Time,” Broder Says In Responding To Criticisms By Cancer Centers

July 7, 1989

In Brief: Fishman La Jolla President Emeritus, Ruoslahti Succeeds Him; Ariz. Seeks Meyskins Replacement

January 13, 1989

ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO.

July 14, 2006

Report Finds NIH Not At Fault in Case Of P-32 Ingestion

September 26, 1997

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

February 23, 1990